BIOMAT Database Logo BIOMAT Database Logo

Tumorigenesis and eye abnormalities in transgenic mice expressing MSV-SV40 large T-antigen. 1990

F Theuring, and W Götz, and R Balling, and H W Korf, and F Schulze, and R Herken, and P Gruss
Max-Planck-Institut für biophysikalische Chemie, Abteilung Molekulare Zellbiologie, Göttingen, Federal Republic of Germany.

Transgenic mice which expressed SV40 large T-antigen under the control of the MSV enhancer and the SV40 promoter were generated. In animals containing an intact MSV enhancer, total lens cataracts and neuroectodermal brain tumors, originating in the pineal organ were observed. In contrast, 5' deletion of the MSV enhancer to a residual 53 bp resulted in a different spectrum of pathologies. Whilst lens cataracts still occurred, no brain tumors could be detected. Instead, fibrosarcomas and adenocarcinomas of the kidneys were induced. In addition, tumors of the endocrine pancreas were observed with both transgene constructs. We conclude that the MSV enhancer element is sufficient to direct the expression of the viral reporter gene to the lens and the pineal organ in transgenic mice. Deletion of the MSV enhancer correlates with the loss of DNA elements responsible for the pineal cell specific expression of SV40 large T-antigen.

UI MeSH Term Description Entries
D008297 Male Males
D008822 Mice, Transgenic Laboratory mice that have been produced from a genetically manipulated EGG or EMBRYO, MAMMALIAN. Transgenic Mice,Founder Mice, Transgenic,Mouse, Founder, Transgenic,Mouse, Transgenic,Mice, Transgenic Founder,Transgenic Founder Mice,Transgenic Mouse
D008980 Moloney murine sarcoma virus A replication-defective murine sarcoma virus (SARCOMA VIRUSES, MURINE) isolated from a rhabdomyosarcoma by Moloney in 1966. Moloney Sarcoma Virus,Sarcoma Virus, Moloney,Virus, Moloney Sarcoma
D009053 Sarcoma Viruses, Murine A group of replication-defective viruses, in the genus GAMMARETROVIRUS, which are capable of transforming cells, but which replicate and produce tumors only in the presence of Murine leukemia viruses (LEUKEMIA VIRUS, MURINE). Finkel-Biskis-Jinkins murine sarcoma virus,Mouse Sarcoma Viruses,FBJ-MSV,FBR-MSV,Finkel-Biskis-Reilly murine sarcoma virus,Finkel Biskis Jinkins murine sarcoma virus,Finkel Biskis Reilly murine sarcoma virus,Murine Sarcoma Viruses,Sarcoma Viruses, Mouse
D009374 Neoplasms, Experimental Experimentally induced new abnormal growth of TISSUES in animals to provide models for studying human neoplasms. Experimental Neoplasms,Experimental Neoplasm,Neoplasm, Experimental
D010641 Phenotype The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment. Phenotypes
D010870 Pineal Gland A light-sensitive neuroendocrine organ attached to the roof of the THIRD VENTRICLE of the brain. The pineal gland secretes MELATONIN, other BIOGENIC AMINES and NEUROPEPTIDES. Epiphysis Cerebri,Pineal Body,Corpus Pineale,Gland, Pineal,Pineal Bodies,Pineal Glands
D001932 Brain Neoplasms Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain. Brain Cancer,Brain Metastases,Brain Tumors,Cancer of Brain,Malignant Primary Brain Tumors,Neoplasms, Intracranial,Benign Neoplasms, Brain,Brain Neoplasm, Primary,Brain Neoplasms, Benign,Brain Neoplasms, Malignant,Brain Neoplasms, Malignant, Primary,Brain Neoplasms, Primary Malignant,Brain Tumor, Primary,Brain Tumor, Recurrent,Cancer of the Brain,Intracranial Neoplasms,Malignant Neoplasms, Brain,Malignant Primary Brain Neoplasms,Neoplasms, Brain,Neoplasms, Brain, Benign,Neoplasms, Brain, Malignant,Neoplasms, Brain, Primary,Primary Brain Neoplasms,Primary Malignant Brain Neoplasms,Primary Malignant Brain Tumors,Benign Brain Neoplasm,Benign Brain Neoplasms,Benign Neoplasm, Brain,Brain Benign Neoplasm,Brain Benign Neoplasms,Brain Cancers,Brain Malignant Neoplasm,Brain Malignant Neoplasms,Brain Metastase,Brain Neoplasm,Brain Neoplasm, Benign,Brain Neoplasm, Malignant,Brain Neoplasms, Primary,Brain Tumor,Brain Tumors, Recurrent,Cancer, Brain,Intracranial Neoplasm,Malignant Brain Neoplasm,Malignant Brain Neoplasms,Malignant Neoplasm, Brain,Neoplasm, Brain,Neoplasm, Intracranial,Primary Brain Neoplasm,Primary Brain Tumor,Primary Brain Tumors,Recurrent Brain Tumor,Recurrent Brain Tumors,Tumor, Brain
D002872 Chromosome Deletion Actual loss of portion of a chromosome. Monosomy, Partial,Partial Monosomy,Deletion, Chromosome,Deletions, Chromosome,Monosomies, Partial,Partial Monosomies
D004742 Enhancer Elements, Genetic Cis-acting DNA sequences which can increase transcription of genes. Enhancers can usually function in either orientation and at various distances from a promoter. Enhancer Elements,Enhancer Sequences,Element, Enhancer,Element, Genetic Enhancer,Elements, Enhancer,Elements, Genetic Enhancer,Enhancer Element,Enhancer Element, Genetic,Enhancer Sequence,Genetic Enhancer Element,Genetic Enhancer Elements,Sequence, Enhancer,Sequences, Enhancer

Related Publications

F Theuring, and W Götz, and R Balling, and H W Korf, and F Schulze, and R Herken, and P Gruss
Tumorigenesis in transgenic mice by a nuclear transport-defective SV40 large T-antigen gene.
September 1987, Virology,
F Theuring, and W Götz, and R Balling, and H W Korf, and F Schulze, and R Herken, and P Gruss
Alterations of the thymic selection process in transgenic mice expressing SV40 large T antigen.
July 1996, International journal of cancer,
F Theuring, and W Götz, and R Balling, and H W Korf, and F Schulze, and R Herken, and P Gruss
Development of thymic carcinoma in transgenic mice expressing SV40 T antigen.
October 1996, Cancer letters,
F Theuring, and W Götz, and R Balling, and H W Korf, and F Schulze, and R Herken, and P Gruss
Hypomyelinating peripheral neuropathies and schwannomas in transgenic mice expressing SV40 T-antigen.
June 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience,
F Theuring, and W Götz, and R Balling, and H W Korf, and F Schulze, and R Herken, and P Gruss
Smooth muscle and bone neoplasms in transgenic mice expressing SV40 T antigen.
October 1994, Oncogene,
F Theuring, and W Götz, and R Balling, and H W Korf, and F Schulze, and R Herken, and P Gruss
Chromosome 8 alterations accompany tumorigenesis in renin-SV40 T antigen transgenic mice.
December 1994, Cancer research,
F Theuring, and W Götz, and R Balling, and H W Korf, and F Schulze, and R Herken, and P Gruss
Erythropoietin-producing cells in transgenic mice expressing SV40 large T antigen directed by erythropoietin control sequences.
April 1994, Annals of the New York Academy of Sciences,
F Theuring, and W Götz, and R Balling, and H W Korf, and F Schulze, and R Herken, and P Gruss
Time-sensitive reversal of hyperplasia in transgenic mice expressing SV40 T antigen.
September 1996, Science (New York, N.Y.),
F Theuring, and W Götz, and R Balling, and H W Korf, and F Schulze, and R Herken, and P Gruss
Trilateral tumors in four different lines of transgenic mice expressing SV40 T-antigen.
February 1996, Investigative ophthalmology & visual science,
F Theuring, and W Götz, and R Balling, and H W Korf, and F Schulze, and R Herken, and P Gruss
Osteosarcomas in transgenic mice expressing an alpha-amylase-SV40 T-antigen hybrid gene.
August 1990, The American journal of pathology,
Copied contents to your clipboard!